Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
Saved in:
Main Authors: | Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleó, Jurgen A. H. R. Claassen, Marcel M. Verbeek |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8bd655e7a32b48debbc472ad6cbb7185 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
by: Tainá M. Marques, et al.
Published: (2021) -
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
by: Zhen-Yi Andy Ou, et al.
Published: (2021) -
COVID‐19‐associated thrombotic angiopathy improved after plasma exchange
by: Natalie Elkayam, et al.
Published: (2021) -
Palinopsia as an initial symptom of cerebral amyloid angiopathy-related inflammation
by: Hitomi Onomura, et al.
Published: (2021) -
Early MRI imaging and follow-up study in cerebral amyloid angiopathy
by: Zhang Shan-chun, et al.
Published: (2021)